Genelux (GNLX) Non-Current Assets (2022 - 2026)
Genelux (GNLX) posted Non-Current Assets of $5.6 million for Q1 2026, up 44.16% on a QoQ basis from $3.9 million in Q4 2025.
Analysis
Genelux (GNLX) Non-Current Assets (2022 - 2026) Analysis & Trends
Genelux has reported Non-Current Assets for 5 years, with the latest figure at $5.6 million in Q1 2026.
- On a quarterly basis, Non-Current Assets changed N/A year-over-year to $5.6 million in Q1 2026; TTM through Sep 2025 was $3.4 million, a 20.17% decrease from a year earlier, with the FY2025 full-year figure at $3.9 million, up 23.01% from the prior year.
- Non-Current Assets was $5.6 million for Q1 2026 at Genelux, up from $3.9 million in the prior quarter.
- The five-year high for Non-Current Assets was $10.3 million in Q2 2024, with the low at $2.9 million in Q3 2023.
- Average Non-Current Assets over 5 years is $4.3 million, with a median of $3.6 million recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Non-Current Assets soared 48.74% in 2024, then sank 70.78% in 2025.
- Over 5 years, Non-Current Assets stood at $3.6 million in 2022, then climbed by 1.4% to $3.7 million in 2023, then slipped by 14.15% to $3.2 million in 2024, then rose by 23.01% to $3.9 million in 2025, then soared by 44.16% to $5.6 million in 2026.
- The last three Non-Current Assets figures came in at $5.6 million (Q1 2026), $3.9 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 60.68 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 35.42 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 14.88 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 23.28 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 5.15 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 938.60 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 24.78 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 564.41 Mn |
| 10 | Genelux | 108.17 Mn | 108.17 Mn | - | 5.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 5.62 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 3.44 Mn |
| Jun 30, 2025 | 3.01 Mn |
| Dec 31, 2024 | 3.17 Mn |
| Sep 30, 2024 | 4.30 Mn |
| Jun 30, 2024 | 10.31 Mn |
| Mar 31, 2024 | 3.47 Mn |
| Dec 31, 2023 | 3.69 Mn |
| Sep 30, 2023 | 2.89 Mn |
| Dec 31, 2022 | 3.64 Mn |